Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00127907
Status:
COMPLETED
Last Update Posted:
2007-10-17
First Post:
2005-08-05
Brief Title:
Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
Comparison of Epinephrine Associated With Vasopressin vs Epinephrine Alone in the Treatment of Out-of-Hospital Cardiac Arrests
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Recent studies have suggested that arginine-vasopressin could be more effective in the treatment of cardiac arrests The last published study did not outline obvious improvements in the prognosis of all cardiac arrests but pointed out a possible increased survival rate when arginine-vasopressin is associated with epinephrine The aim of this study is to compare the efficacy of two successive injections of epinephrine 1 mg with two successive injections of epinephrine associated with arginine-vasopressin 40 UI in out-of-hospital cardiac arrests occurring in adult patients The primary endpoint is the survival rate at hospital admission The inclusion period lasts 18 months and 2416 patients are planned to be enrolled
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None